https://arginasesignals.com/in....dex.php/il-35-and-il
Transplantation of mesenchymal stem cells (MSCs) is an emerging healing method for PAD. Nonetheless, the method by which individual placenta-derived mesenchymal stem cells (PMSCs) control macrophage differentiation in ischemic structure remains uncertain. MATERIAL AND METHODS Placentas were obtained from healthier donors with typical 38- to 40-week gestation, and PMSCs were isolated from the placentas and cultured. A mouse model of hind-limb ischemia ended up being establ